Cause of death, by non-communicable diseases, ages 0-4, female in Africa Eastern and Southern
Africa Eastern and Southern: Cause of death, by non-communicable diseases, ages 0-4, female was 7.5% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4, female in Africa Eastern and Southern, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 0-4.
Analysis
Africa Eastern and Southern recorded 7.5% for cause of death, by non-communicable diseases, ages 0-4, female in 2021.
The figure is down 1.6% on the previous year and up 27.9% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, female in Africa Eastern and Southern peaked at 7.7% in 2019 and was at its lowest, 3.9%, in 2000.
That places Africa Eastern and Southern 38th out of 47 groups with data for 2021, putting it in the bottom quarter.
Cause of death, by non-communicable diseases, ages 0-4, female in Africa Eastern and Southern, year by year
| Year | % of total female deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 3.9% | — |
| 2010 | 5.8% | +47.8% |
| 2015 | 7.3% | +25.7% |
| 2019 | 7.7% | +4.4% |
| 2020 | 7.6% | -0.9% |
| 2021 | 7.5% | -1.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.9% | 3.9% | 3.9% | 1 |
| 2010s | 6.9% | 5.8% | 7.7% | 3 |
| 2020s | 7.5% | 7.5% | 7.6% | 2 |
Countries ranked near Africa Eastern and Southern
More health data for Africa Eastern and Southern
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, annual growth rate 4.21 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0196 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 3.96 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0232 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, per capita 0.0284 units per person (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, female in Africa Eastern and Southern?
- Cause of death, by non-communicable diseases, ages 0-4, female in Africa Eastern and Southern was 7.5% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, female recorded in Africa Eastern and Southern?
- The highest recorded value was 7.7% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, female recorded in Africa Eastern and Southern?
- The lowest recorded value was 3.9% in 2000.
- How does Africa Eastern and Southern rank for cause of death, by non-communicable diseases, ages 0-4, female?
- Africa Eastern and Southern ranks 38th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, female rising or falling in Africa Eastern and Southern?
- Over the last ten years it is up 27.9%. The long-run trend across the full record is rising.
- Where does this Africa Eastern and Southern data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.